Published November 2019 | Version v1
Journal article

Breast cancer phenotype influences MRI response evaluation after neoadjuvant chemotherapy

  • 1. Prevention Institute - Hospital de Câncer de Barretos, Campinas, SP (Brazil)
  • 2. Imaging Department - A.C.Camargo Cancer Center, São Paulo, SP (Brazil)

Description

Highlights: • Breast MRI has 80% accuracy in the prediction of pCR after NAC. • MRI sensitivity was higher for Her-2 overexpressed and triple-negative subtypes. • Pre-treatment NME negatively affect MRI performance to assess response after NAC. - Abstract: PurposeTo evaluate which factors may influence magnetic resonance imaging (MRI) performance in the detection of pathologic complete response (pCR) after neoadjuvant chemotherapy (NAC).

Availability note (English)

Available from http://dx.doi.org/10.1016/j.ejrad.2019.108701

Additional details

Identifiers

DOI
10.1016/j.ejrad.2019.108701;
PII
S0720048X19303511;

Publishing Information

Journal Title
European Journal of Radiology
Journal Volume
120
Journal Page Range
p. 108701
ISSN
0720-048X
CODEN
EJRADR

INIS

Country of Publication
Netherlands
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
51013516
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Descriptors DEI
CHEMOTHERAPY; EVALUATION; FORECASTING; MAGNETIC RESONANCE; MAMMARY GLANDS; NEOPLASMS; NMR IMAGING; PERFORMANCE; PHENOTYPE; POLYMERASE CHAIN REACTION; SENSITIVITY
Descriptors DEC
BODY; DIAGNOSTIC TECHNIQUES; DISEASES; GENE AMPLIFICATION; GLANDS; MEDICINE; ORGANS; RESONANCE; THERAPY

Optional Information

Notes
© 2019 Elsevier B.V. All rights reserved.